SciSparc Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.3M-54.6% YoYTTM through 30 Jun 2025
Net Income -$7.5MTTM through 30 Jun 2025
Free Cash Flow -$5.1MTTM through 30 Jun 2025
Margins
| Current | |
|---|---|
| Gross Margin | 73.6% |
| EBITDA Margin | -549.2% |
| Operating Margin | -978.3% |
| Net Margin | -572.1% |
Returns
-164.8%ROA
Balance Sheet Health
Debt / Equity-4.52x
Current Ratio0.55x
Net Debt-$4.2Mnet cash position
Cash & Equivalents$1.5M
Quality Metrics
Piotroski F-Score1 / 9
FCF Margin-391.4%
Multi-Year Trend
RevenueFY2024: $1.3M
Diluted EPSFY2024: $1.28
Dividend
No dividend
Capital Allocation
Capex Intensity0.6%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.